Company intelligence / Profile preview

Somnics

Hsinchu, Hsinchu, Taiwansomnics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Somnics has developed and commercialized the iNAP Sleep Therapy System, a mask-free, intraoral negative air pressure device for treating obstructive sleep apnea. The system is FDA-cleared for all severities of OSA, CE-marked, and available in multiple global markets. Clinical data show an average adherence rate of 65% after one year among U.S. users; ongoing post-market clinical research is being conducted to further validate outcomes.[5] The device allows titration of negative pressure settings to optimize efficacy and comfort.[6] It is positioned as a patient-friendly alternative to CPAP with growing adoption worldwide.

Therapeutic areas: Pulmonology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

American Heart Association Heart and Brain Health Accelerator program participant

Beyond the preview

Go deeper on Somnics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somnics.

Explore the full profile